<DOC>
	<DOCNO>NCT00260390</DOCNO>
	<brief_summary>Growing evidence support notion Late-onset Dysthymic disorder middle age men may associate age-related HPG hypofunctioning . In study seek examine efficacy Testosterone replacement condition . Hypothesis : Testosterone replacement effective placebo , treat men late onset Dysthymic Disorder hypo-gonadism .</brief_summary>
	<brief_title>Testosterone Replacement Middle-Aged Hypogonadal Men With Dysthymia : Parallel Group , Double Blind Randomized Trial</brief_title>
	<detailed_description />
	<mesh_term>Dysthymic Disorder</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>1 . Male , age 4080 year . 2 . Diagnosed hypogonadism ( total T level 350 ng/dl ) , previously treat . 3 . Diagnosis Dysthymic disorder onset age 40 . 4 . PSA &lt; 4.0 . 5 . Normal digital exam prostate precede 1 year . 6 . For subject currently take antidepressant : Current antidepressant treatment last 6 week longer , decent dose remission ( partial remission HAMD &gt; 12 ) . 7 . Able give inform consent . 1 . Acute , severe , unstable prostatitis , symptomatic prostatic hypertrophy , polycythemia , severe acne , breast cancer , prostate cancer , hypopituitarism . 2 . Currently treat testosterone . 3 . Meets lifetime criterion schizophrenia , schizoaffective disorder , bipolar disorder ( i.e. , BPI , BPII , BP NOS ) ; major depressive episode precede 5 year . 4 . Current suicidal risk . 5 . Current ( past year ) substance abuse dependence .</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2006</verification_date>
	<keyword>Dysthymic Disorder</keyword>
	<keyword>HPG hypofunctioning</keyword>
	<keyword>Testosterone replacement</keyword>
</DOC>